BOD Australia Limited (ASX:BDA)
Bod Australia Limited (ASX:BDA) operates two integrated business units. The Company is a developer and distributor of cosmetics, natural medicines and health supplements, focused on all natural, evidence based products. Bod has developed a significant distribution footprint in the Australian market with access to over 900 pharmacies, department stores and specialty retailers and is also targeting Asian markets through key daigou relationships.
The Company is also building a multi-faceted cannabis business, which is underpinned by a supply and collaboration agreement with Swiss botanical extracts manufacturer, Linnea Natural Pharma Solutions and an exclusive licence and manufacturing agreement with Singapore listed company iX Biopharma.
Bod Australia Limited aims to develop a range of over the counter and therapeutic products based on GMP-certified cannabis extracts, which have the potenital to be licenced or sold to major pharmaucetical companies on a global scale.
The Company is underpinned by an experienced Board and management team who aim to grow sales and profitability through commerical opportunites in the health and wellness space.